8-K: Henry Schein Executive James Breslawski Departs
Executive Transition
Henry Schein, Inc. announced the departure of James Breslawski from his Senior Advisor role, effective September 5, 2025.
Summary
- James Breslawski has transitioned out of his role as Senior Advisor and member of the Executive Management Committee at Henry Schein, Inc.
- The transition was effective on September 5, 2025.
- Mr. Breslawski will receive payments and benefits in accordance with the Company's Executive Severance Plan.
Sentiment
Score: 5
Explanation: Neutral. The filing reports a planned executive transition, which is a routine corporate event. No immediate positive or negative financial implications are evident from this disclosure alone.
Future Outlook
NA
Industry Context
This executive transition is a company-specific event and does not immediately reflect broader industry trends or competitive shifts within the dental and medical supply sectors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Senior Advisor and member of the Executive Management Committee | James Breslawski | NA | 2025-09-05 | Transitioned out of current role; will receive payments and benefits under the Company's Executive Severance Plan. |
Stakeholder Impact
- Shareholders: Minimal direct impact as this appears to be a planned executive departure, but ongoing monitoring of leadership structure and succession planning is prudent.
- Employees: Likely minimal impact given the prior disclosure, suggesting a well-managed transition.
Key Dates
| Date | Description |
|---|---|
| 2025-04-01 | James Breslawski transitioned from President to Senior Advisor and member of the Executive Management Committee. |
| 2025-09-05 | James Breslawski transitioned out of his Senior Advisor and Executive Management Committee role. |
| 2025-09-09 | Date of filing of the 8-K report with the SEC. |
Recommendation
holdThe filing details a planned executive transition, which is a routine corporate event and was previously disclosed in part. There are no new material financial or operational details that would warrant a change in investment stance. Investors should monitor future disclosures for any strategic shifts or new leadership appointments.
Keywords
Henry Schein, HSIC, James Breslawski, Executive Departure, Management Change, Senior Advisor, Severance Plan, 8-K Filing, Dental Supply, Medical Supply
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.